Session Information

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

    All times listed are in Mountain Time MDT (UTC-6:00)

    PL - Plenary
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    WS - Workshops
    IS - Industry Symposium
    MTE - Meet the Expert
    BEDG - Brain Exchange Discussion Groups

Filter Results:

Show Only CME Accredited Sessions

  • +

    FP07 - Mesothelioma, Thymoma and Other Thoracic Malignancies

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters (Featured)
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • +

      FP07.05 - DREAM3R: Durvalumab With Chemotherapy as First Line Treatment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial

      00:00 - 00:00  |  Presenter: Anna Nowak

      • Abstract

      Loading...

  • +

    ES05 - A New Era of Treatment and Diagnosis for Mesothelioma and Thymoma*

    • 09:00 - 09:35
    • 9/10/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES05.01 - Molecular Markers in Mesothelioma

      09:00 - 09:02  |  Presenter: Jennifer L. Sauter

      • Abstract

      No abstract available for this presentation

    • +

      ES05.02 - Advances in Immunotherapy in Malignant Pleural Mesothelioma

      09:02 - 09:04  |  Presenter: Arnaud Scherpereel

      • Abstract

      No abstract available for this presentation

    • +

      ES05.03 - CAR T-cell Therapy in Mesothelioma and Thymic Cancer

      09:04 - 09:06  |  Presenter: Joachim G.J.V. Aerts

      • Abstract

      No abstract available for this presentation

    • +

      ES05.04 - The Latest Updates in Thymoma

      09:06 - 09:08  |  Presenter: Meinoshin Okumura

      • Abstract

      No abstract available for this presentation

    • +

      ES05.05 - Live Discussion with Speakers

      09:08 - 09:35

      • Abstract

      No abstract available for this presentation

  • +

    OA13 - Topics of Pleural Mesothelioma

    • 17:30 - 18:30
    • 9/12/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • +

      OA13.01 - S1619 A Trial of Neoadjuvant Cisplatin-Pemetrexed With Atezolizumab in Combination and Maintenance for Resectable Pleural Mesothelioma

      17:30 - 17:40  |  Presenter: Anne Tsao

      • Abstract

      Loading...

  • +

    OA15 - Upcoming Molecular Targeted Agents for EGFR exon 20 Insertion and MET Skipping Mutation

    • 18:45 - 19:45
    • 9/12/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Novel Therapeutics and Targeted Therapies
    • +

      OA15.01 - Mobocertinib in EGFR Exon 20 Insertion–Positive Metastatic NSCLC Patients With Disease Control on Prior EGFR TKI Therapy

      18:45 - 18:55  |  Presenter: Alexander Spira

      • Abstract

      Loading...